Home/Filings/4/0001209191-20-040404
4//SEC Filing

Wade M. Andrew 4

Accession 0001209191-20-040404

CIK 0001323885other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:46 PM ET

Size

5.0 KB

Accession

0001209191-20-040404

Insider Transaction Report

Form 4
Period: 2020-06-30
Wade M. Andrew
Vice President, Finance
Transactions
  • Award

    Common Stock

    2020-06-30$28.11/sh+364$10,232140,537 total
Footnotes (2)
  • [F1]Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2020.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 1, 2020, which was the first trading day of the applicable offering period. The closing price on January 1, 2020 was $33.07.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001560591

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:46 PM ET
Size
5.0 KB